M. Ward

发表

Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data

J. Stamford, M. O'Neill, D. J. Osborne, 1999, Brain Research.

Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.

M. O'Neill, H. Allain, C. Hicks, 1998, European journal of pharmacology.

Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia

P. Ornstein, M. O'Neill, D. Bleakman, 1998, Neuropharmacology.

The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia.

J. Gilmore, M. O'Neill, D. Bleakman, 1996, European journal of pharmacology.

Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.

P. Ornstein, M. O'Neill, D. Schoepp, 2000, The Journal of pharmacology and experimental therapeutics.

LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia

M. O'Neill, D. Lodge, J. Monn, 1999, Neuroscience Letters.

Neuroprotective effects of the neuronal Ca(2+) channel blockers, LY042826 and LY393615 in vivo.

M. O'Neill, C. Hicks, M. Ward, 2000, European journal of pharmacology.

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

E. Nisenbaum, K. Whalley, P. Skolnick, 2003, Journal of Pharmacology and Experimental Therapeutics.

Amphetamine promotes task-dependent recovery following focal cortical ischaemic lesions in the rat

S. Iversen, D. Bannerman, M. O'Neill, 2005, Behavioural Brain Research.

ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia

Todd R. Wiernicki, M. O'Neill, D. Lodge, 2000, Brain Research.

Electrical and Network Neuronal Properties Are Preferentially Disrupted in Dorsal, But Not Ventral, Medial Entorhinal Cortex in a Mouse Model of Tauopathy

Jonathan T. Brown, M. Goodfellow, K. Phillips, 2016, The Journal of Neuroscience.

LY 503430 , a novel AMPA receptor potentiator with functional , neuroprotective and neurotrophic effects in rodent models of Parkinson ’ s disease

E. Nisenbaum, K. Whalley, P. Skolnick, 2003 .

LY 503430 , a Novel-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional , Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson ’ s Disease

E. Nisenbaum, K. Whalley, P. Skolnick, 2003 .

The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments.

M. Danhof, M. O'Neill, M. Merlini, 2008, Journal of pharmacological and toxicological methods.

Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia

J. Panetta, C. Hicks, M. Ward, 1997, Brain Research.

Altered Synapse Stability in the Early Stages of Tauopathy

J. Isaac, M. Hutton, AndrewD . Randall, 2017, Cell reports.

A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

Zeshan Ahmed, Tracey K. Murray, Markus Tolnay, 2014, Acta Neuropathologica.

Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo.

M. O'Neill, D. Bleakman, C. Hicks, 1997, European journal of pharmacology.

Differential activation of PKCδ in the substantia nigra of rats following striatal or nigral 6‐hydroxydopamine lesions

M. O'Neill, S. Wonnacott, T. Murray, 2008, The European journal of neuroscience.

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

K. Whalley, P. Skolnick, M. O'Neill, 2004, European journal of pharmacology.

NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus.

M. O'Neill, D. Lodge, A. Bond, 1999, European journal of pharmacology.

LY393615, a novel neuronal Ca2+ and Na+ channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia

J. Stamford, K. Mathews, J. Gilmore, 2001, Brain Research.

LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia

Y. Michotte, P. Ornstein, M. O'Neill, 2000, Neuropharmacology.

Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease

M. O'Neill, S. Duty, T. Murray, 2002, Pharmacology Biochemistry and Behavior.

Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia.

M. O'Neill, C. Hicks, M. Ward, 1996, European journal of pharmacology.

The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques

Steven C. R. Williams, L. Gregory, M. O'Neill, 2003, Brain Research.

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.

J. Swettenham, M. O'Neill, C. Hicks, 1999, European journal of pharmacology.

Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia

M. O'Neill, D. Dobson, C. Hicks, 1999, Brain Research.